Using a genetic, observational study as a strategy to estimate the potential cost-effectiveness of pharmacological CCR5 blockade in dialysis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using a genetic, observational study as a strategy to estimate the potential cost-effectiveness of pharmacological CCR5 blockade in dialysis patients

Published:2011-07 Issue:7 Volume:21 Page:417-425
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Muntinghe Friso L.H.,Vegter Stefan,Verduijn Marion,Boeschoten Elisabeth W.,Dekker Friedo W.,Navis Gerjan,Postma Maarten

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference49 articles.

1. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.;Fellstrom;N Engl J Med,2009

2. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials.;Heerspink;Lancet,2009

3. RD costs and returns by therapeutic category.;DiMasi;Clinical and Non-Clinical Drug Development,2004

4. Natures randomised trials.;Hingorani;Lancet,2005

5. Mendelian randomization: prospects, potentials, and limitations.;Smith;Int J Epidemiol,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Kidney Transplantation Decision Modelling Studies;Applied Health Economics and Health Policy;2022-08-09

2. Expression of Chemokine Receptors on Peripheral Blood T Cells in Children with Chronic Kidney Disease;Mediators of Inflammation;2015

3. Developments in renal pharmacogenomics and applications in chronic kidney disease;Pharmacogenomics and Personalized Medicine;2014-08

4. Cost-effectiveness of enzyme replacement therapy for Fabry disease;Orphanet Journal of Rare Diseases;2013-02-19

5. CCR5Δ32 Genotype Leads to a Th2 Type Directed Immune Response in ESRD Patients;PLoS ONE;2012-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3